Women were less than half of the people tested for almost all of these common medicines.
PregnancyCommunity forum

NCT00108082

The CLEVER Study - Coreg And Left Ventricular Mass Regression

See it on ClinicalTrials.gov ↗

287 people

128 womenmiddle line = equal numbers159 men
Phase
PHASE3
Paid for by
GlaxoSmithKline
Finished
2008-08
Health conditions
Hypertrophy, Left Ventricular
Who could join
Anyone
Ages
18 Years – 80 Years
Average age
mean 56.7 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 71.8% · Black / African American 21.6% · Not reported 4.2% · Asian 1% · American Indian / Alaska Native 0.7% · More than one race 0.7%

Women left out

  • No women who could get pregnant

    Most women roughly 15–50 years old were turned away.

    “Females of childbearing potential.”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    “Has uncontrolled diabetes, uncontrollable or symptomatic arrhythmias, unstable angina, second or third degree heart block, history of MI, COPD (chronic obstructive pulmonary disease), liver or kidney disease.”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “Takes beta-blocker for MI (myocardial infarction) or arrhythmia.”
  • No diabetes

    Women with diabetes were turned away.

    “Has uncontrolled diabetes, uncontrollable or symptomatic arrhythmias, unstable angina, second or third degree heart block, history of MI, COPD (chronic obstructive pulmonary disease), liver or kidney disease.”

Study titles and rules are shown in their original English.